Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
202M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
14.2M
-
Shares change
-
+2.79M
-
Total reported value, excl. options
-
$108M
-
Value change
-
+$9.71M
-
Put/Call ratio
-
7.63
-
Number of buys
-
58
-
Number of sells
-
-22
-
Price
-
$7.63
Significant Holders of ATAI Life Sciences N.V. - Common Shares (ATAI) as of Q4 2021
102 filings reported holding ATAI - ATAI Life Sciences N.V. - Common Shares as of Q4 2021.
ATAI Life Sciences N.V. - Common Shares (ATAI) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.2M shares
of 202M outstanding shares and own 7.04% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (2.13M shares), MORGAN STANLEY (1.77M shares), BlackRock Inc. (957K shares), Woodline Partners LP (838K shares), CITADEL ADVISORS LLC (649K shares), PURA VIDA INVESTMENTS, LLC (553K shares), Brown University (530K shares), MILLENNIUM MANAGEMENT LLC (513K shares), GROUP ONE TRADING, L.P. (459K shares), and TWO SIGMA INVESTMENTS, LP (414K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.